Beclabuvir in combination with asunaprevir and daclatasvir for hepatitis C virus genotype 1 infection: A systematic review and meta‐analysis

@article{Ahmed2018BeclabuvirIC,
  title={Beclabuvir in combination with asunaprevir and daclatasvir for hepatitis C virus genotype 1 infection: A systematic review and meta‐analysis},
  author={A. Ahmed and Mohamed Fahmy Doheim and O. Mattar and Nourin Ali Sherif and Duy Hieu Truong and P. Hoa and K. Hirayama and N. Huy},
  journal={Journal of Medical Virology},
  year={2018},
  volume={90},
  pages={907 - 918}
}
  • A. Ahmed, Mohamed Fahmy Doheim, +5 authors N. Huy
  • Published 2018
  • Biology, Medicine
  • Journal of Medical Virology
  • Daclatasvir, asunaprevir (ASV), and beclabuvir (BCV) are direct‐acting antivirals (DAAs) for patients with hepatitis C virus genotype 1 infection. This systematic review and meta‐analysis investigating the efficacy and safety of this three‐drug combination in HCV genotype 1 infection. Eleven electronic search engines were searched for relevant publications. Studies were screened for eligibility and data was extracted. The outcomes were pooled as event rate and risk ratio (RR). The protocol was… CONTINUE READING

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 74 REFERENCES